Purchases and Sales Made in Q1 2020 in Neuro Bo Pharmaceuticals, Inc. (NRBO)
This table provides information about the institutional ownership of Neuro Bo Pharmaceuticals, Inc. (NRBO) during Q1 2020. The information is specifically focused on institutions that hold shares of NeuroBo Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 14, 2020
Q1 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
101KNew |
$734K - $3.04M
|
101K
$274K
|
|
May 15, 2020
Q1 2020
|
Exodus Point Capital Management, LP
New York, NY |
BUY
|
- |
42.8KNew |
$310K - $1.28M
|
42.8K
$116K
|
|
May 15, 2020
Q1 2020
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
362New |
$2.62K - $10.9K
|
362
$977
|
|
May 15, 2020
Q1 2020
|
Macquarie Group LTD
Australia, C3 |
BUY
|
- |
286New |
$2.07K - $8.58K
|
286
$772
|
|
May 04, 2020
Q1 2020
|
Victory Capital Management Inc
|
BUY
|
- |
156+ 283.64% |
$1.13K - $4.68K
|
211
$570
|
|
May 14, 2020
Q1 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
18New |
$130 - $540
|
18
$48.6
|
|
May 13, 2020
Q1 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Apr 28, 2020
Q1 2020
|
Exchange Capital Management, Inc.
|
SELL
|
- |
-24- 0.12% |
$174 - $720
|
19.7K
$53.3K
|
|
May 01, 2020
Q1 2020
|
Ubs Group Ag
|
SELL
|
- |
-782Closed |
$5.66K - $23.5K
|
0
$0
|